Journal ArticleDOI
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review
TLDR
In the direct acting antiviral treatment era, well-designed studies evaluating interventions to enhance a simplified care cascade are crucial in facilitating treatment scale-up.About:
This article is published in International Journal of Drug Policy.The article was published on 2017-09-01. It has received 158 citations till now. The article focuses on the topics: Clinical trial.read more
Citations
More filters
Journal ArticleDOI
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Graham S Cooke,Isabelle Andrieux-Meyer,Tanya L. Applegate,Rifat Atun,Jessica R Burry,Hugo Cheinquer,G.M. Dusheiko,Jordan J. Feld,Charles Gore,Max Griswold,Saeed Hamid,Margaret Hellard,Jinlin Hou,J. Howell,Jidong Jia,Natalia Kravchenko,Jeffrey V. Lazarus,Maud Lemoine,Olufunmilayo A. Lesi,Liudmyla Maistat,Brian J. McMahon,Homie Razavi,Teri Roberts,Bryony Simmons,Mark W. Sonderup,C Wendy Spearman,Bridie E Taylor,David L. Thomas,Imam Waked,John W. Ward,Stefan Wiktor,Ayman Abdo,Rakesh Aggarwal,Alessio Aghemo,Bandar Al-Judaibi,Mamun Al Mahtab,Arshad Altaf,Zyaad Ameen,Tarik Asselah,Oidov Baatarkkhuu,Ella Barber,Eleanor Barnes,Pascale Boulet,Louise Burrows,Maia Butsashvili,Erica Chan,Chelsea Chow,Ben Cowie,Chris Cunningham,Alexandre de Araujo,Graciela Diap,G.J. Dore,Joseph Doyle,Manal Elsayed,Emmanuel Fajardo,Edward Gane,Aneley Getahun,David J. Goldberg,Tiffany Got,Matthew Hickman,Andrew F. Hill,Sharon J. Hutchinson,Christopher R. Jones,Saleem Kamili,Amreen Khan,Alice Lee,Tin Yan Lee,Jioiji Malani,Tammy Meyers Morris,Shevanthi Nayagam,Richard Njouom,Ponsiano Ocama,Alisa Pedrana,Rosanna W. Peeling,Amulya Reddy,Jilian A. Sacks,Shiv Kumar Sarin,Yusuke Shimakawa,Marcela Silva,Pavlo Skala,Simon D. Taylor-Robinson,Alexander J. Thompson,Mark Thursz,Alfred Tonganibeia,Jack Wallace,James Ward,Fernando Herz Wolff,Peter Vickerman,Johnny Yau +88 more
TL;DR: Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020.
Journal ArticleDOI
Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis
TL;DR: Responsibility to DAA therapy was favourable among people with recent drug use (including those who inject) and those receiving opioid substitution therapy, supporting broadening access in these populations.
Journal ArticleDOI
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs
Jason Grebely,Sarah Larney,Amy Peacock,Samantha Colledge,Janni Leung,Janni Leung,Matthew Hickman,Peter Vickerman,Sarah Blach,Evan B Cunningham,Kostyantyn Dumchev,Michael T. Lynskey,Jack Stone,Adam Trickey,Homie Razavi,Richard P. Mattick,Michael Farrell,Gregory J. Dore,Louisa Degenhardt +18 more
TL;DR: Although, globally, 39.2% of people with recent injecting drug use are living with hepatitis C virus (HCV) and 8.5% of all HCV infections occur globally among people with recently injected drug use, there is wide variation among countries and regions.
Journal ArticleDOI
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Jason Grebely,Gregory J. Dore,Sébastien Morin,Jürgen K. Rockstroh,Jürgen K. Rockstroh,Marina B. Klein,Marina B. Klein +6 more
TL;DR: Grebely et al. as discussed by the authors discussed why PWID should be considered as a priority population in these efforts, reasons why this goal could be attainable among PWID, challenges that need to be overcome, and key recommendations for action.
References
More filters
Journal ArticleDOI
Experience of hepatitis C testing among injecting drug users in Sydney, Australia.
Carolyn Day,Bethany White,Hla-Hla Thein,Anna Doab,Gregory J. Dore,Anna Bates,J. Holden,Lisa Maher +7 more
TL;DR: High prevalence of testing suggests good uptake and high acceptability among this population in Australia, and the majority of participants (HIV 62%; HCV 59%) reported that they would prefer pre-test counselling to be delivered in person rather than receiving written information and would prefer test results to be delivery face-to-face.
Journal ArticleDOI
Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre.
Adam Newman,Shelley Beckstead,David Beking,Susan Finch,Tina Knorr,Carol Lynch,Meredith MacKenzie,Daphne Mayer,Brenda Melles,Ron Shore +9 more
TL;DR: It is suggested that not only is successful treatment of chronic HCV infection in current and former injection drug users with concurrent psychiatric disorders possible, but the benefits of such treatment delivered in a community-based, multidisciplinary, primary care model may extend beyond narrowly defined virological outcomes.
Journal ArticleDOI
Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours.
TL;DR: There are high rates of risk-taking behaviour among this group of psychiatric inpatients, which may contribute to the higher prevalence of hepatitis C compared to the general population.
Journal ArticleDOI
Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting
TL;DR: In addicted patients a high CHC treatment and viral eradication rate in a primary care setting in Switzerland is feasible and Opioid substitution seems a beneficial framework for CHC care in this “difficult to treat” population.
Journal ArticleDOI
Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre
M. Mofizul Islam,Libby Topp,Katherine M. Conigrave,Katherine M. Conigrave,Katherine M. Conigrave,Ann White,Sharon Reid,Sara Grummett,Paul S. Haber,Paul S. Haber,Carolyn Day +10 more
TL;DR: The relatively high uptake of referrals, the number of individuals commencing AVT and final treatment outcomes are reasonably encouraging, highlighting the potential of targeted PHC services to facilitate reductions in liver disease burden among IDUs.
Related Papers (5)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach,Stefan Zeuzem,Michael Manns,Ibrahim Altraif,Ann-Sofi Duberg,David H. Muljono,Imam Waked,Seyed M Alavian,Mei Hsuan Lee,Francesco Negro,Faisal Abaalkhail,Ahmed Abdou,Maheeba Abdulla,Antoine Abou Rached,Inka Aho,Ulus Salih Akarca,Imad Al Ghazzawi,Saad Al Kaabi,Faryal Al Lawati,Khalid Al Namaani,Youssif Al Serkal,Said A. Al-Busafi,Layla Al-Dabal,Soo Aleman,Abdullah S. Alghamdi,Abdulrahman Aljumah,Hamad Al-Romaihi,Monique Andersson,Vic Arendt,Perttu Arkkila,Abdullah M. Assiri,Oidov Baatarkhuu,Abate Bane,Ziv Ben-Ari,Colm Bergin,Fernando Bessone,Florian Bihl,Abdul Rahman Bizri,M. Blachier,Antonio Javier Blasco,Carlos E Brandão Mello,Philip Bruggmann,Cheryl Brunton,Filipe Calinas,Henry Lik-Yuen Chan,Asad Chaudhry,Hugo Cheinquer,Chien-Jen Chen,Rong-Nan Chien,Moon Seok Choi,Peer Brehm Christensen,Wan-Long Chuang,Vladimir Chulanov,Laura Cisneros,Mette Rye Clausen,Matthew E. Cramp,Antonio Craxì,E. A. Croes,Olav Dalgard,Jorge Daruich,Victor de Ledinghen,Gregory J. Dore,Manal H El-Sayed,Gül Ergör,Gamal Esmat,Chris Estes,Karolin Falconer,Elmoubashar Farag,Maria Lucia Gomes Ferraz,Paulo R. Ferreira,Robert Flisiak,Sona Frankova,Ivane Gamkrelidze,Edward Gane,Javier García-Samaniego,Akram Khan,Ilias Gountas,Adrian Goldis,Magnus Gottfredsson,Jason Grebely,Michael Gschwantler,Mario G. Pessoa,Jessie Gunter,Behzad Hajarizadeh,Omer Hajelssedig,Saeed Hamid,Waseem Hamoudi,Angelos Hatzakis,Sayed Himatt,Harald Hofer,Irena Hrstić,Yee Tak Hui,Béla Hunyady,Ramazan Idilman,Wasim Jafri,Rohani Jahis,Naveed Z. Janjua,Peter Jarcuska,Agita Jeruma,Jon G. Jonasson,Yasser Kamel,Jia-Horng Kao,Sabahattin Kaymakoglu,David Kershenobich,Jawad Khamis,Young Sik Kim,Loreta A. Kondili,Zaher Koutoubi,Mel Krajden,Henrik Krarup,Moon sing Lai,Wim Laleman,Wai-cheung C Lao,Daniel Lavanchy,Pablo Lázaro,Henri Leleu,Olufunmilayo A. Lesi,Laurentius A. Lesmana,Michael Li,Valentina Liakina,Young-Suk Lim,Boris Lukšić,Adam Mahomed,Matti Maimets,Mihály Makara,Abraham O. Malu,Rui Tato Marinho,Paul Marotta,Stefan Mauss,Muhammad S. Memon,Maria C Mendes Correa,Nahum Méndez-Sánchez,Shahin Merat,Ammal M. Metwally,Rosmawati Mohamed,Christophe Moreno,Fadi H. Mourad,Beat Müllhaupt,Kimberly Murphy,Helen Nde,Richard Njouom,Diana Nonković,Suzanne Norris,Solomon Obekpa,Stephen Oguche,S. Olafsson,Marian Oltman,Ogu Omede,CE Omuemu,Ohene Opare-Sem,Anne Øvrehus,Shirley Owusu-Ofori,Tsendsuren S. Oyunsuren,George V. Papatheodoridis,Ken Pasini,Kevork M. Peltekian,Richard Phillips,N. N. Pimenov,Hossein Poustchi,Nishi Prabdial-Sing,Huma Qureshi,Alnoor Ramji,Devin Razavi-Shearer,Kathryn Razavi-Shearer,Berhane Redae,Henk W. Reesink,Ezequiel Ridruejo,Sarah Robbins,Lewis R. Roberts,Stuart K. Roberts,William Rosenberg,Françoise Roudot-Thoraval,Stephen D. Ryder,Rifaat Safadi,Olga Sagalova,Riina Salupere,Faisal M. Sanai,Juan F.Sanchez Avila,Vivek A. Saraswat,Rui Sarmento-Castro,Christoph Sarrazin,Jonathan Schmelzer,Ivan Schréter,Carole Seguin-Devaux,Samir Shah,Ala I. Sharara,Manik Sharma,Anatoly Shevaldin,Gamal Shiha,William Sievert,Mark W. Sonderup,Kyriakos Souliotis,Danute Speiciene,Jan Sperl,Peter Stärkel,Rudolf E. Stauber,Catherine A.M. Stedman,Daniel Struck,Tung-Hung Su,Vana Sypsa,Soek Siam Tan,Junko Tanaka,Alexander J. Thompson,Ieva Tolmane,Krzysztof Tomasiewicz,Jonas Valantinas,Pierre Van Damme,Adriaan J. van der Meer,Ingo van Thiel,Hans Van Vlierberghe,Adriana Vince,Wolfgang Vogel,Heiner Wedemeyer,Nina Weis,Vincent Ws Wong,Cesar Yaghi,Ayman Yosry,Man-Fung Yuen,Evy Yunihastuti,Aasim Yusuf,Eli Zuckerman,Homie Razavi +221 more